Related Experiment Video
Updated: Jun 17, 2026
09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Is there an ACE ID - ACTN3 R577X polymorphisms interaction that influences sprint performance?
1Zinman College of Physical Education and Sports Sciences at the Wingate Institute, Genetics and Molecular Biology, Netanya, Israel. eynon@wincol.ac.il
International Journal of Sports Medicine
|December 17, 2009
Summary
Sprint performance is linked to specific gene variations. The ACTN3 RR genotype with the ACE I allele, and the ACE II genotype with the ACTN3 R allele, are associated with being a sprinter.
Area of Science:
- Genetics
- Sports Science
- Human Performance
Background:
- The alpha-actinin-3 (ACTN3) R577X polymorphism and the angiotensin converting enzyme (ACE) ID polymorphism are known to influence athletic performance.
- Understanding the combined effects of these genetic variations on sprint ability is crucial for sports science research.
Purpose of the Study:
- To investigate the association between ACTN3 R577X and ACE ID gene polymorphisms and sprint performance in Israeli athletes.
- To determine if specific genotype combinations predict sprint ability.
Main Methods:
- Case-control study involving 81 sprinters and 240 healthy controls.
- Genotyping for ACTN3 R577X (rs1815739) and ACE ID (rs5186) polymorphisms.
- Statistical analysis including odds ratios and confidence intervals to assess genotype-phenotype associations.
Main Results:
- The ACE II genotype combined with the ACTN3 R allele showed a significant association with sprinters compared to controls (P=0.003).
- The ACTN3 RR genotype combined with the ACE I allele also showed a significant association with sprinters (P=0.001).
- Individuals with ACTN3 RR + ACE I allele (OR 2.67) and ACE II + ACTN3 R allele (OR 3.57) had a significantly higher probability of being sprinters.
Conclusions:
- Specific combinations of ACTN3 R577X and ACE ID genotypes are associated with sprint ability.
- These genotype combinations increase the likelihood of an individual being a sprinter but do not correlate with the elite level of performance.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:09Epistasis Analysis
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...